Overview ESMO Therapeutic Landscapes 2026 is set to explore the safety profiles and clinical management of next-generation biologics, with a focused session on the toxicity of multispecific antibodies and immune-cell engagers. Scheduled for February 18, 2026, this technical webinar brings together leading oncologists, immunologists, and translational researchers to dissect risk factors, mechanism-based toxicities, and practical…